Statin use and the risk of esophageal cancer: a population-based case-control study

Use of Statin Medications and Risk of Esophageal Adenocarcinoma in Persons with Barrett's Esophagus

(2012) E. D. Kantor et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Exposure to statins and risk of common cancers: a series of nested case-control studies

(2011) Yana Vinogradova et al.   BMC CANCER

Nonsteroidal Anti-Inflammatory Drugs and Statins Have Chemopreventative Effects in Patients With Barrett's Esophagus

(2011) Florine Kastelein et al.   GASTROENTEROLOGY

Medications (NSAIDs, Statins, Proton Pump Inhibitors) and the Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus

(2010) Dang M. Nguyen et al.   GASTROENTEROLOGY

Analgesic use and the risk for progression of chronic kidney disease

(2010) Hsin-Wei Kuo et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Medication Usage and the Risk of Neoplasia in Patients With Barrett's Esophagus

(2009) Dang M. Nguyen et al.   Clinical Gastroenterology and Hepatology

Statins inhibit NK‐cell cytotoxicity by interfering with LFA‐1‐mediated conjugate formation

(2009) Patrick C. Raemer et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Statins in Esophageal Cancer Cell Lines: Promising Lead?

(2008) Ernest T. Hawk et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Statins Inhibit Proliferation and Induce Apoptosis in Barrett's Esophageal Adenocarcinoma Cells

(2008) Olorunseun O. Ogunwobi et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Do statins prevent or promote cancer?

(2008) Mark R Goldstein et al.   Current Oncology

The double-edged sword of statin immunomodulation

(2008) Mark R. Goldstein et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells

(2007) Karin Mausner-Fainberg et al.   ATHEROSCLEROSIS